Method for analysis and selection of human ovarian tissue for grafting in an immune-isolating capsule

TECHNOLOGY NUMBER: 2024-096
Technology No. 2023-500

OVERVIEW

Artificial intelligence automated analysis of human ovarian tissue for graft selection. 

  • Automated follicle counting predicts graft longevity over manual visual inspection methods. 
  • Selection of optimal ovarian tissue grafts for encapsulated transplantation procedures. 


BACKGROUND

Ovarian tissue preservation and grafting require selecting viable tissues to restore endocrine function and fertility. Historically, assessing ovarian tissue relies on manual visual inspection, standard histology, and basic image processing macros or traditional algorithms to identify and classify follicles. These traditional techniques suffer from significant shortcomings, including high subjective variability, time-consuming manual labor, and limited accuracy when predicting the longevity and functional capacity of the tissue. Current approaches fail to precisely quantify follicle density across adjacent tissue sections, leading to inconsistent graft quality and unpredictable outcomes in transplantation. Consequently, there is a clear need for an improved, objective, and automated system capable of high-throughput qualitative and quantitative analysis to reliably select optimal ovarian tissue sections and predict long-term graft function prior to therapeutic implantation.


INNOVATION

The proposed technology utilizes an automated, trained artificial intelligence program combined with specialized image processing macros to perform precise quantitative and qualitative analysis of human ovarian tissue. Histologically processed, sectioned, and stained whole-slide images are processed using software-trained annotations to automate follicle identification and counting. By accurately measuring follicle numbers in a specific tissue section, the system extrapolates follicle density to adjacent tissues. This technical advancement enables the objective selection of high-quality tissue sections and reliable prediction of graft functional longevity before clinical use. Real-world applications include guiding the selection of optimal ovarian tissue grafts for immune-isolating capsule transplantation, assisting reproductive endocrinologists, and serving as an automated tissue analysis platform for biomedical research laboratories.


ADDITIONAL INFORMATION

INTELLECTUAL PROPERTY

Patent Pending


RELATED TECHNOLOGY


  • expand_more mode_edit Inventor (3)
    Ariella Shikanov
    Colleen Flanagan
    Gabrielle Blevins
  • expand_more cloud_download Supporting documents (1)
    Product brochure
    Method for analysis and selection of human ovarian tissue for grafting in an immune-isolating capsule.pdf
Questions about this technology?